Barclays analyst Julian Mitchell raised the firm’s price target on General Electric to $96 from $92 and keeps an Overweight rating on the shares. Ahead of the impending healthcare spin, the analyst updated GE headline forecasts to exclude HealthCare. The price target rises given the higher when-issued value for HealthCare than a prior valuation of the business, Mitchell tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on GE:
- GE among companies studying Medtronic businesses, Bloomberg reports
- Medtronic Business Units Spin-Off Attracts Siemens and GE
- Largest borrow rate increases among liquid names
- General Electric, TransnetBW sign contract to redesign Pulverdingen 380 kV
- ELPEDISON selects GE Digital APM reliability application